Nurix Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein modulation drugs for the treatment of cancer and inflammatory diseases. With a cutting-edge platform, Nurix aims to address previously undruggable targets and create innovative therapeutics with the potential to transform patient outcomes.
